WGS Investor Alert: Levi & Korsinsky Investigates GeneDx Holdings Corp. (WGS) for Potential Securities Fraud

GeneDx CFO promised quarterly profitability weeks before the company posted an $8.2 million adjusted loss -- and then cut full-year guidance by approximately 12%. NEW YORK, May 13, 2026 /PRNewswire/ -- Investors in GeneDx Holdings Corp. (NASDAQ: WGS) lost approximately 44% of their share value after Q1 2026 earnings revealed a significant revenue miss and a roughly 12% cut to full-year guidance.